These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9331107)

  • 1. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
    Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN
    Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
    Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
    Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
    Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
    Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer.
    Tamada H; Kitazawa R; Gohji K; Kitazawa S
    J Bone Miner Res; 2001 Mar; 16(3):487-96. PubMed ID: 11277266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study.
    Spanjol J; Djordjević G; Markić D; Klarić M; Fuckar D; Bobinac D
    Coll Antropol; 2010 Apr; 34 Suppl 2():119-25. PubMed ID: 21302710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.
    Autzen P; Robson CN; Bjartell A; Malcolm AJ; Johnson MI; Neal DE; Hamdy FC
    Br J Cancer; 1998 Nov; 78(9):1219-23. PubMed ID: 9820184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bone morphogenetic protein-7 (BMP-7) in human prostate.
    Masuda H; Fukabori Y; Nakano K; Shimizu N; Yamanaka H
    Prostate; 2004 Apr; 59(1):101-6. PubMed ID: 14991870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
    Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
    Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
    J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
    Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
    Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma.
    Basic-Jukic N; Radic-Antolic M; Hudolin T; Coric M; Zadro R; Pasini J; Kastelan Z; Kes P
    Kidney Blood Press Res; 2009; 32(6):445-50. PubMed ID: 20016212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins are expressed by both bone-forming and non-bone-forming lesions.
    Khurana JS; Ogino S; Shen T; Parekh H; Scherbel U; DeLong W; Feldman MD; Zhang PJ; Wolfe HJ; Alman BA
    Arch Pathol Lab Med; 2004 Nov; 128(11):1267-69. PubMed ID: 15508192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
    Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.